Andrew Malcolmson

Andrew Malcolmson has an extensive work experience in various leadership roles in the healthcare and medical technology industry.

Andrew is currently the President & CEO of Fifth Eye Inc., where they lead the company in applying data science to address complex clinical challenges.

Prior to that, they served as the VP R&D/Marketing/Product Management at Envista Holdings Corporation and played a key role in the divestiture of the CS Solutions Business Unit at Carestream Dental.

Andrew also held leadership positions at Hach, Invacare Corporation, Medtronic, Covidien, Cyteline LLC, Claro Scientific LLC, and Malvern Instruments.

In these roles, they demonstrated their expertise in digital solutions, health informatics, marketing, and business development, contributing to the development and launch of innovative products and solutions.

Overall, Andrew Malcolmson's work experience highlights their leadership abilities, strategic mindset, and strong industry knowledge in the healthcare and medical technology sectors.

Andrew Malcolmson has a Master of Science degree in Aerospace Engineering from the University of Florida. Additionally, they have a Bachelor of Applied Science degree in Chemical Engineering from the University of Ottawa. The specific start and end years for their education are not provided.